facebook tracking

Department of Pharmaceuticals

Department of Pharmaceuticals Revises Funding and Grant-Release Provisions for Medical Device Skill Development Scheme


regulatory illustration
Manufacturer   |   Source: Department of Pharmaceuticals
Published On: 08-10-2026

Enforcement Date: 08 October, 2026
Department of Pharmaceuticals Revises Funding and Grant-Release Provisions for Medical Device Skill Development Scheme

The Department of Pharmaceuticals has issued a corrigendum modifying the operational guidelines of the Capacity Building and Skill Development for Medical Devices sub-scheme under the Strengthening of Medical Device Industry scheme. The amendments revise grant-release mechanisms, introduce two-instalment funding, strengthen utilisation reporting requirements, and specify conditions for releasing financial assistance to beneficiary institutions and selected participants.


The Department of Pharmaceuticals has amended several provisions of the operational guidelines for the Capacity Building and Skill Development for Medical Devices sub-scheme, following the decision taken at the 5th Scheme Steering Committee meeting held on 21 September 2026.


Key points include:

  1. Financial assistance of up to 75% of the approved course cost or ₹21 crore, whichever is lower, will be provided as grant-in-aid in two instalments instead of on a reimbursement basis.
  2. The remaining 25% of the approved cost must be borne by the beneficiary institution.
  3. Funding under Component A will be divided into 70% for non-recurring expenses (infrastructure, laboratory equipment and machinery) and 30% for recurring expenses (salary, wages and consumables).
  4. Beneficiary institutions must submit monthly project status and expenditure reports, along with certified expenditure statements.
  5. Institutions must execute an indemnity bond before receiving grants and demonstrate their contribution towards the project cost.
  6. Faculty support for eligible multidisciplinary courses will be provided in advance, subject to the institution's commitment to sustain faculty through its own resources.
  7. Funding for eligible selected participants will also be released in two advance instalments.
  8. All other provisions of the existing operational guidelines remain unchanged.

Applicable For: Manufacturer
Reference Number: सं0 / No. 31026/64/2024-MD(E-29857) Notification Link

Related Regulatory Updates

Contact us

Please feel free to talk to us if you have any questions. We endeavour to answer within 24 hours.